<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>E-selectin, which is a member of the selectin superfamily of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecules, contributes to the leukocyte-endothelial cell attachments and is involved in the pathogenesis of thrombovascular diseases as a consequence </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated the A561C mutation in the E-selectin gene in 235 Japanese patients with ischemic cerebrovascular disease (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) and 301 age- and sex-matched healthy controls </plain></SENT>
<SENT sid="2" pm="."><plain>Excluding the subjects with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo>, the AC genotype frequencies of patients with ischemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> were higher than those of controls: 12.7% vs. 5.8% (P=0.04) </plain></SENT>
<SENT sid="3" pm="."><plain>Our results show that E-selectin gene polymorphisms represent an increased risk for ischemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> in the Japanese population without <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo> </plain></SENT>
</text></document>